explore -WSS

explore

author：leisure time 2025-10-03 00:08:19 - browse：412

Two researchers look at a projection screen displaying medical devices, scientific graphs and DNA — health tech coverage from STAT — Adobe

The federal government’s plan to boost its oversight of the use of artificial intelligence tools in health care drew censure from startups arguing that overregulation stifles new ideas. But as Washington forges ahead, founders say they’re in the dark about who will be regulated and how — and they’re urging policymakers to offer clarity.

As they race for a slice of the $4 trillion U.S. health care market, AI founders and investors say regulatory uncertainty is a hurdle, forcing them to build more slowly and meticulously document for fear of potential audits. That makes it harder to keep up with the tech industry’s breakneck pace, they tell STAT.

The regulatory uncertainty adds to the many challenges dogging young health tech ventures today: Last year investments in digital health startups shriveled to their lowest annual total since 2019, and leaders are desperate to preserve what little funds they have, including through layoffs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Supreme Court mifepristone arguments center on docs' right to sue

WSS

How the political right came to back psychedelics to treat trauma

Readout Newsletter: Merck, Vertex, and Viking updates

Study says nonprofit hospitals fall short in charity care spending

HCA discloses massive data breach affecting 11 million patients

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Study: Pain burden is higher in Black NFL players than white ones

knowledge

explore

hotspot

Supreme Court strikes down use of affirmative action

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Dobbs anniversary: the lost opportunity of abortion as health care

Supreme Court mifepristone arguments center on docs' right to sue

Anesthesiologist group: stop taking Ozempic before surgery

Why ADHD is under

At least 13 dead in Texas as scorching temps continue

Lecanemab for Alzheimer's is coming. Is the health system ready?

What does generative AI mean for health care? We asked experts

Why the world’s most expensive drug might be worth the price

focus

Covid vaccine financial winners and losers, from Pfizer to Novavax

Steward Health Care has deal to sell doctor network to UnitedHealth

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Why 40% Americans with Parkinson’s don’t see a neurologist

Scientists boost immune system in aging mice by making it youthful

It's time to get medical device identifiers over the finish line

hotspot

entertainment

knowledge

focus